AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Agilent Technologies Inc. (A)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

147.04

-1.59 (-1.07%)

At close: Feb 04, 2025, 3:59 PM

147.04

0.00%

After-hours Feb 04, 2025, 07:00 PM EST

undefined% (undefined)

Bid	145
Market Cap	41.99B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	4.42
PE Ratio (ttm)	33.27
Forward PE	n/a
Analyst	Hold

Ask	147.05
Volume	1,024,603
Avg. Volume (20D)	1,835,015
Open	148.02
Previous Close	148.63
Day's Range	146.27 - 148.63
52-Week Range	124.16 - 155.35
Beta	undefined

About A

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorpt...

[Show more]

Industry Medical - Diagnostics & Research

Sector Healthcare

IPO Date Nov 18, 1999

Employees 17,400

Stock Exchange NYSE

Ticker Symbol A

Website https://www.agilent.com

Analyst Forecast

According to 14 analyst ratings, the average rating for A stock is "Hold." The 12-month stock price forecast is $150, which is an increase of 2.01% from the latest price.

Buy 42.86%

Hold 42.86%

Sell 7.14%

Stock Forecasts

Next Earnings Release

Agilent Technologies Inc. is scheduled to release its earnings on Feb 26, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

+0.49%

Agilent Technologies shares are trading lower afte... Unlock content with Pro Subscription

5 months ago

+0.16%

Agilent Technologies shares are trading higher after B of A Securities and Evercore ISI Group raised their respective price targets on the stock.

News

1 week ago · businesswire.com

Agilent to Announce First-Quarter Fiscal Year 2025 Financial Results on Feb. 26

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2025 after the stock market closes on Wednesday, Feb. 26. ...

1 week ago · businesswire.com

Agilent Automated Workflows at SLAS2025: Connecting with Confidence

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today that it will feature new automated laboratory workflow solutions at the SLAS2025 International Conference & Ex...

2 weeks ago · zacks.com

Agilent Rises 11% in a Year: Should You Buy, Sell or Hold the Stock?

A faces challenges with slowing end-market demand and regulatory hurdles in China, raising growth concerns.

2 weeks ago · seekingalpha.com

Agilent Technologies, Inc. (A) J.P. Morgan 43rd Annual Healthcare Conference (Transcript)

Agilent Technologies, Inc. (NYSE:A ) J.P. Morgan 43rd Annual Healthcare Conference January 14, 2025 12:45 PM ET Company Participants Padraig McDonnell - President and CEO Robert McMahon - Senior VP an...

1 month ago · zacks.com

Agilent (A) Up 1.3% Since Last Earnings Report: Can It Continue?

Agilent (A) reported earnings 30 days ago. What's next for the stock?

1 month ago · zacks.com

Is the Options Market Predicting a Spike in Agilent (A) Stock?

Investors need to pay close attention to Agilent (A) stock based on the movements in the options market lately.

1 month ago · businesswire.com

Agilent to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Bob McMahon will present at the 43rd Annual J.P. Morgan Healthcare Conferen...

1 month ago · https://thefly.com

Agilent investor day calls for margin expansion, says Goldman Sachs

Goldman Sachs keeps a Buy rating and $150 price target on Agilent after the company's investor day presentation. The firm's main takeaways from the event are the forecast for operating margin expansio...

1 month ago · youtube.com

Agilent CEO Padraig McDonnell sees 'long runway' in advancing therapeutics

Padraig McDonnell, Agilent CEO, joins 'Closing Bell Overtime' to talk investors day, its healthcare segment, and more.

1 month ago · businesswire.com

Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the issuing of a Class C companion diagnostic In Vitro Diagnostic Regulation (IVDR) certification for PD-L1 IH...

1 month ago · zacks.com

Agilent Gains 5% in a Month: Should You Buy, Sell or Hold the Stock?

A's shares ride on the bright performance of the Agilent CrossLab Group segment and strategic acquisitions.

2 months ago · zacks.com

International Markets and Agilent (A): A Deep Dive for Investors

Examine Agilent's (A) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

2 months ago · zacks.com

Agilent Q4 Earnings Surpass Estimates, Revenues Increase Y/Y

A's fourth-quarter 2024 results benefit from strong demand in the ACG segment. However, declining sales in the Americas and China markets raise concerns.

2 months ago · seekingalpha.com

Agilent Q4: Expecting Market Recovery In 2025

I reiterate a “Buy” rating on Agilent Technologies, Inc. with a one-year target price of $150 per share, driven by strategic growth and market recovery. Agilent's acquisition of BIOVECTRA will enhance...

2 months ago · seekingalpha.com

Agilent Technologies, Inc. (A) Q4 2024 Earnings Call Transcript

Agilent Technologies, Inc. (NYSE:A ) Q4 2024 Results Conference Call November 25, 2024 4:30 PM ET Company Participants Parmeet Ahuja - Vice President, Investor Relations Padraig McDonnell - President ...

2 months ago · zacks.com

Agilent (A) Reports Q4 Earnings: What Key Metrics Have to Say

The headline numbers for Agilent (A) give insight into how the company performed in the quarter ended October 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates...

2 months ago · zacks.com

Dow and Small-Caps Close at New All-Time Highs

The Dow closed at a fresh new high at 44,736, +440 points on the day, and the Russell 2000 notched its first all-time closing high since 2021.

2 months ago · zacks.com

Agilent Technologies (A) Beats Q4 Earnings and Revenue Estimates

Agilent Technologies (A) came out with quarterly earnings of $1.46 per share, beating the Zacks Consensus Estimate of $1.41 per share. This compares to earnings of $1.38 per share a year ago.

2 months ago · reuters.com

Medical equipment maker Agilent's downbeat annual forecast clouds fourth-quarter beat

Agilent forecast its annual profit below analysts' estimates on Monday, as a recovery is ongoing in the market for medical tools and equipment used in clinical studies, sending its shares down more th...

2 months ago · businesswire.com

Agilent Reports Fourth-Quarter Fiscal Year 2024 Financial Results

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.70 billion for the fourth quarter ended October 31, 2024, an increase of 0.8% reported and a decl...

Load More News